MedTrace Logo

MH004 Topical Cream in Healthy Adult Volunteers and Participants With Atopic Dermatitis or Rheumatoid Arthritis

NCT04815148 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2021-03-24

No results posted yet for this study

Summary

This is a Phase Ia/Ib Study of MH004 in Healthy Adult Volunteers, participants with Mild to Moderate Atopic Dermatitis and participants with Mild to Moderate Rheumatoid Arthritis.

Conditions

Interventions

DRUG

MH004 Ia(0.1%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ia(0.3%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ia(1%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ia(3%)

Spread approx. 1 g of MH004 topical cream to the upper thigh skin.

DRUG

MH004 Ib-1(0.1%)

Spread approx. 0.5 g of MH004 topical cream to the area of Target AD Lesions.

DRUG

MH004 Ib-1(0.3%)

Spread approx. 0.5 g of MH004 topical cream to the area of Target AD Lesions.

DRUG

MH004 Ib-1(1%)

Spread approx. 0.5 g of MH004 topical cream to the area of Target AD Lesions.

DRUG

MH004 Ib-2(0.3%)

Spread approx. 0.5 g of MH004 topical cream to the Target Joint.

DRUG

MH004 Ib-2(1%)

Spread approx. 0.5 g of MH004 topical cream to the Target Joint.

DRUG

MH004 Ib-2(3%)

Spread approx. 0.5 g of MH004 topical cream to the Target Joint.

Sponsors & Collaborators

  • Minghui Pharmaceutical Pty Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2022-03-31
Completion
2022-03-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04815148 on ClinicalTrials.gov